Source:http://linkedlifedata.com/resource/pubmed/id/21151173
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
2011-4-21
|
pubmed:abstractText |
Our previous studies have found that activation of Wnt/?-catenin signaling resulted in mouse prostatic intraepithelial neoplasia (mPIN). In the large probasin promoter directed SV40-large T-antigen (LPB-Tag) expressing mouse prostate, mPIN forms with rare areas of adenocarcinoma. Combining expression of both Wnt-signaling and Tag expression in the mouse prostate, we have studied the role of Wnt/?-catenin signaling in the progression from mPIN to adenocarcinoma. Our results show that the prostates of mice expressing Tag alone or nuclear ?-catenin alone developed mPIN, whereas the activation of both Tag and the Wnt/?-catenin pathway resulted in invasive prostate adenocarcinoma. Furthermore, Foxa2, a forkhead transcription factor, was induced by active Wnt/?-catenin signaling, and the expression of Foxa2 was associated with the invasive phenotype in the primary prostate cancer. In the LPB-Tag/dominant active (DA) ?-catenin prostates, MMP7, a Wnt/?-catenin target gene, was upregulated. Furthermore, we also assessed AR and AR signaling pathway in these LPB-Tag/DA ?-catenin mice. Although ?-catenin is a well-known AR co-activator in vitro, our study provides strong in vivo evidences indicating that both AR protein and the AR pathway were downregulated in the prostate of LPB-Tag/DA ?-catenin mice. Histological analysis shows that prostate sections derived from the LPB-Tag/DA ?-catenin mice display neuroendocrine differentiation (NED), but NE cancer does not develop. Together, our findings indicate that Wnt/?-catenin signaling has an important role in the progression of mPIN to prostate adenocarcinoma.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1476-5594
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
21
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1868-79
|
pubmed:dateRevised |
2011-10-21
|
pubmed:meshHeading |
pubmed-meshheading:21151173-Adenocarcinoma,
pubmed-meshheading:21151173-Animals,
pubmed-meshheading:21151173-Disease Progression,
pubmed-meshheading:21151173-Male,
pubmed-meshheading:21151173-Mice,
pubmed-meshheading:21151173-Prostatic Neoplasms,
pubmed-meshheading:21151173-Receptors, Androgen,
pubmed-meshheading:21151173-Signal Transduction,
pubmed-meshheading:21151173-Wnt Proteins,
pubmed-meshheading:21151173-beta Catenin
|
pubmed:year |
2011
|
pubmed:articleTitle |
Wnt/?-catenin activation promotes prostate tumor progression in a mouse model.
|
pubmed:affiliation |
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|